Anti-FGF8抗体[MM0291-8D24] (ab89550)
Key features and details
- Mouse monoclonal [MM0291-8D24] to FGF8
- Suitable for: IHC-P, WB, Neutralising
- Reacts with: Human
- Isotype: IgG1
概述
-
产品名称
Anti-FGF8抗体[MM0291-8D24]
参阅全部 FGF8 一抗 -
描述
小鼠单克隆抗体[MM0291-8D24] to FGF8 -
宿主
Mouse -
经测试应用
适用于: IHC-P, WB, Neutralisingmore details -
种属反应性
与反应: Human -
免疫原
Recombinant full length Human FGF8 protein.
-
阳性对照
- WB: Human placenta tissue lysate.
-
常规说明
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. -
存储溶液
Constituent: PBS -
Concentration information loading...
-
纯度
Protein G purified -
纯化说明
The IgG fraction of culture supernatant was purified by Protein G affinity chromatography and filtered through a 0.2 µm filter. -
克隆
单克隆 -
克隆编号
MM0291-8D24 -
同种型
IgG1 -
研究领域
相关产品
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab89550于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
IHC-P | (1) |
Use at an assay dependent concentration.
|
WB |
1/500 - 1/1000. Predicted molecular weight: 27 kDa.
|
|
Neutralising |
Use at an assay dependent concentration.
|
说明 |
---|
IHC-P
Use at an assay dependent concentration. |
WB
1/500 - 1/1000. Predicted molecular weight: 27 kDa. |
Neutralising
Use at an assay dependent concentration. |
靶标
-
功能
Stimulates growth of the cells in an autocrine manner. Mediates hormonal action on the growth of cancer cells. -
疾病相关
Defects in FGF8 are the cause of Kallmann syndrome type 6 (KAL6) [MIM:612702]. Kallmann syndrome is a disorder that associates hypogonadotropic hypogonadism and anosmia. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In some patients other developmental anomalies can be present, which include renal agenesis, cleft lip and/or palate, selective tooth agenesis, and bimanual synkinesis. In some cases anosmia may be absent or inconspicuous.
Defects in FGF8 are a cause of idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110]. IHH is defined as a deficiency of the pituitary secretion of follicle-stimulating hormone and luteinizing hormone, which results in the impairment of pubertal maturation and of reproductive function. -
序列相似性
Belongs to the heparin-binding growth factors family. -
发展阶段
In adults expression is restricted to the gonads. -
细胞定位
Secreted. - Information by UniProt
-
数据库链接
- Entrez Gene: 2253 Human
- Omim: 600483 Human
- SwissProt: P55075 Human
- Unigene: 57710 Human
-
别名
- AIGF antibody
- Androgen induced growth factor antibody
- Androgen-induced growth factor antibody
see all
图片
-
Anti-FGF8 antibody [MM0291-8D24] (ab89550) at 1/500 dilution + Human placenta tissue lysate
Predicted band size: 27 kDa
Observed band size: 23 kDa why is the actual band size different from the predicted?
数据表及文件
-
Datasheet download
文献 (0)
ab89550 尚未被引用在任何文献中。